chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: "the same side effects that she had when she had the COVID-19 virus"; This spontaneous case was reported by a patient family member or friend and describes the occurrence of ADVERSE EVENT ("the same side effects that she had when she had the COVID-19 virus") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT ("the same side effects that she had when she had the COVID-19 virus"). At the time of the report, ADVERSE EVENT ("the same side effects that she had when she had the COVID-19 virus") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Caller did not know specific side effects were or other pertinent information.  Concomitant product use was not provided by the reporter.   Treatment information was not provided.   This case was linked to MOD21-074395 (Linked Report). This case was linked to MOD-2021-074907 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic, Urticaria, Vaccination site rash
Clinical narrative: Rash around the shot area; rash is itchy; hives all over the body; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (Rash around the shot area), RASH PRURITIC (rash is itchy) and URTICARIA (hives all over the body) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash around the shot area), RASH PRURITIC (rash is itchy) and URTICARIA (hives all over the body). At the time of the report, VACCINATION SITE RASH (Rash around the shot area), RASH PRURITIC (rash is itchy) and URTICARIA (hives all over the body) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Nonsignificant follow up appended on 13-APR-2021 with No new information
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Vertigo
Clinical narrative: Dizziness; Vertigo; About to fall and being off balance; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VERTIGO (Vertigo) and BALANCE DISORDER (About to fall and being off balance) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), VERTIGO (Vertigo) and BALANCE DISORDER (About to fall and being off balance). At the time of the report, DIZZINESS (Dizziness), VERTIGO (Vertigo) and BALANCE DISORDER (About to fall and being off balance) had resolved.            No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-075059 (Patient Link).   Reporter did not allow further contact
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product contamination physical
Clinical narrative: black particles in it/ pharmacist administered three doses to three patients from this vial; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT CONTAMINATION PHYSICAL (black particles in it/ pharmacist administered three doses to three patients from this vial) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PRODUCT CONTAMINATION PHYSICAL (black particles in it/ pharmacist administered three doses to three patients from this vial). On 13-Apr-2021, PRODUCT CONTAMINATION PHYSICAL (black particles in it/ pharmacist administered three doses to three patients from this vial) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Per reporter: Vial with black particles in it was administered to three patients.  Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Alopecia totalis, Pruritus, Skin irritation, Trichorrhexis
Clinical narrative: alopecia totalis; eyebrows and eyelashes itch/facial hair; This has happened in my facial hair and scalp too; (eyebrows and eyelashes itched) and then fell out; This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA TOTALIS (alopecia totalis), PRURITUS (eyebrows and eyelashes itch/facial hair), SKIN IRRITATION (This has happened in my facial hair and scalp too) and TRICHORRHEXIS ((eyebrows and eyelashes itched) and then fell out) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 015M20A) for COVID-19 vaccination.     Reportedly patient had alopecia symptoms in the past, around 20 years ago, and in that time he treated it with injections in scalp, and an off brand use of an steroid cream, and the areas where he applied it grew back.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALOPECIA TOTALIS (alopecia totalis), PRURITUS (eyebrows and eyelashes itch/facial hair), SKIN IRRITATION (This has happened in my facial hair and scalp too) and TRICHORRHEXIS ((eyebrows and eyelashes itched) and then fell out). At the time of the report, ALOPECIA TOTALIS (alopecia totalis), PRURITUS (eyebrows and eyelashes itch/facial hair), SKIN IRRITATION (This has happened in my facial hair and scalp too) and TRICHORRHEXIS ((eyebrows and eyelashes itched) and then fell out) had not resolved. Not Provided          Concomitant product use was not provided by the reporter.   Patient did not receive a treatment yet for his symptoms.   This case was linked to US-MODERNATX, INC.-MOD-2021-075114 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075114:dose 1 case
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Urinary incontinence
Clinical narrative: Excessive urination; Right arm pain; This spontaneous case was reported by a patient and describes the occurrence of URINARY INCONTINENCE (Excessive urination) and PAIN IN EXTREMITY (Right arm pain) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040AZ1A) for COVID-19 vaccination.     Previously administered products included for Influenza immunization: Flu shot. Past adverse reactions to the above products included Pain in arm with Flu shot. Concurrent medical conditions included Allergy to chemicals. Concomitant products included CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced URINARY INCONTINENCE (Excessive urination) and PAIN IN EXTREMITY (Right arm pain). At the time of the report, URINARY INCONTINENCE (Excessive urination) had resolved and PAIN IN EXTREMITY (Right arm pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information after first dose of vaccine was not provided.   This case was linked to MOD-2021-075102 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Malaise, Nausea, Oropharyngeal pain
Clinical narrative: Sore throat; Fatigue; Nausea; Diarrhea; Feel very sick; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (Diarrhea), MALAISE (Feel very sick), OROPHARYNGEAL PAIN (Sore throat), FATIGUE (Fatigue) and NAUSEA (Nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure, Cholesterol and Acid reflux (esophageal).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced DIARRHOEA (Diarrhea). 09-Apr-2021, the patient experienced MALAISE (Feel very sick), FATIGUE (Fatigue) and NAUSEA (Nausea). On 10-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) for Sore throat, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), FATIGUE (Fatigue) and NAUSEA (Nausea) had not resolved and MALAISE (Feel very sick) and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Blood pressure pills, acid reflux pill and cholesterol pill.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary incontinence, Urinary tract pain
Clinical narrative: irritation and pain; excessive urination; This spontaneous case was reported by a patient and describes the occurrence of URINARY INCONTINENCE (excessive urination) and URINARY TRACT PAIN (irritation and pain) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU (Patient only had sore arm.) in October 2020. Concurrent medical conditions included Sulfonamide allergy (Sulfur allergy). Concomitant products included CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Apr-2021, the patient experienced URINARY INCONTINENCE (excessive urination). On an unknown date, the patient experienced URINARY TRACT PAIN (irritation and pain). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Pain, at an unspecified dose and frequency. At the time of the report, URINARY INCONTINENCE (excessive urination) was resolving and URINARY TRACT PAIN (irritation and pain) had resolved. Not Provided          Patient had adverse events with both doses of Moderna, but the second shot was much "more pronounced."  The irritation and pain from urination subsided after he took Motrin for lower back pain and it has not come back. 90 percent of his urinary flow went back to normal but when he drinks water there is still a sudden urge to go.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Product dose omission issue
Clinical narrative: 2-3 weeks after shot, my father developed shingles; Has not received his second dose since the first one was given in February; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (2-3 weeks after shot, my father developed shingles) and PRODUCT DOSE OMISSION ISSUE (Has not received his second dose since the first one was given in February) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (2-3 weeks after shot, my father developed shingles) and PRODUCT DOSE OMISSION ISSUE (Has not received his second dose since the first one was given in February). At the time of the report, HERPES ZOSTER (2-3 weeks after shot, my father developed shingles) and PRODUCT DOSE OMISSION ISSUE (Has not received his second dose since the first one was given in February) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.   Event occurred 2-3 weeks after first dose. His second dose was scheduled 17Mar2021 but he missed this appointment due to his illness.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased
Clinical narrative: shortness of breath; faster heart beat while walking; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath) and HEART RATE INCREASED (faster heart beat while walking) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21 and 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced DYSPNOEA (shortness of breath) and HEART RATE INCREASED (faster heart beat while walking). At the time of the report, DYSPNOEA (shortness of breath) and HEART RATE INCREASED (faster heart beat while walking) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Non significant follow up received on 05-MAY-2021, Event outcome updated.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Nausea, Pain in extremity
Clinical narrative: so sick; her arm still hurts from shoulder to hand; still feels nauseated; headaches; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MALAISE (so sick), PAIN IN EXTREMITY (her arm still hurts from shoulder to hand), NAUSEA (still feels nauseated) and HEADACHE (headaches) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (so sick), PAIN IN EXTREMITY (her arm still hurts from shoulder to hand), NAUSEA (still feels nauseated) and HEADACHE (headaches). At the time of the report, MALAISE (so sick) outcome was unknown and PAIN IN EXTREMITY (her arm still hurts from shoulder to hand), NAUSEA (still feels nauseated) and HEADACHE (headaches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Nausea, Vomiting
Clinical narrative: Diarrhoea; Vomiting; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea), VOMITING (Vomiting), NAUSEA (Nausea) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, ESCITALOPRAM OXALATE (LEXAPRO) and CELECOXIB (CELEBREX) for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced DIARRHOEA (Diarrhoea), VOMITING (Vomiting), NAUSEA (Nausea) and FATIGUE (Fatigue). On 11-Apr-2021, VOMITING (Vomiting) and NAUSEA (Nausea) had resolved. At the time of the report, DIARRHOEA (Diarrhoea) had not resolved and FATIGUE (Fatigue) outcome was unknown.            Treatment included gatorade and water for diarrhea.   For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for covid after first dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for covid after first dose). At the time of the report, COVID-19 (Tested positive for covid after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Headache, Nausea
Clinical narrative: Swelling in the left arm the size of a golf ball; Mark on arm itched; Red brown circle; Head was pounding; Chills; Throbbing forhead headaches; Fever; Achy; Nauseated; Very tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Swelling in the left arm the size of a golf ball), HEADACHE (Throbbing forhead headaches), PYREXIA (Fever), PAIN (Achy) and NAUSEA (Nauseated) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Hives), Drug allergy (Hives), Asthma since 25-Aug-1999 and Lymphedema since 15-Jul-2021.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced HEADACHE (Throbbing forhead headaches), PYREXIA (Fever), PAIN (Achy), NAUSEA (Nauseated) and FATIGUE (Very tired). On 23-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling in the left arm the size of a golf ball), PRURITUS (Mark on arm itched), ERYTHEMA (Red brown circle), HEADACHE (Head was pounding) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Throbbing headache, at an unspecified dose and frequency and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) for Headache, at an unspecified dose and frequency. On 29-Mar-2021, PERIPHERAL SWELLING (Swelling in the left arm the size of a golf ball), PAIN (Achy), NAUSEA (Nauseated), FATIGUE (Very tired), PRURITUS (Mark on arm itched), ERYTHEMA (Red brown circle), HEADACHE (Head was pounding) and CHILLS (Chills) had resolved. At the time of the report, HEADACHE (Throbbing forhead headaches) had not resolved and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow-up received contain Significant information- 2nd dose information, Contains updated adverse event information. Contains treatment medication information. On 05-Aug-2021: Follow up received contains Significant information-New event added-Fever,The start date of events- extreme fatigue, achy, nauseated changes from 23-MAR-2021 to 21-MAR-2021.Contains updated Event outcome-Recover, Contains new medical history, Reporter information-Address, Contains updated patient demographics- Patient, also include-Hight, Weight, Race and Ethnicity.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: Swelling in the left arm the size of a golf ball; Mark on arm itched; Red brown circle; Head was pounding; Chills; Throbbing forhead headaches; Fever; Achy; Nauseated; Very tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Swelling in the left arm the size of a golf ball), HEADACHE (Throbbing forhead headaches), PYREXIA (Fever), PAIN (Achy) and NAUSEA (Nauseated) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Hives), Drug allergy (Hives), Asthma since 25-Aug-1999 and Lymphedema since 15-Jul-2021.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced HEADACHE (Throbbing forhead headaches), PYREXIA (Fever), PAIN (Achy), NAUSEA (Nauseated) and FATIGUE (Very tired). On 23-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling in the left arm the size of a golf ball), PRURITUS (Mark on arm itched), ERYTHEMA (Red brown circle), HEADACHE (Head was pounding) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Throbbing headache, at an unspecified dose and frequency and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) for Headache, at an unspecified dose and frequency. On 29-Mar-2021, PERIPHERAL SWELLING (Swelling in the left arm the size of a golf ball), PAIN (Achy), NAUSEA (Nauseated), FATIGUE (Very tired), PRURITUS (Mark on arm itched), ERYTHEMA (Red brown circle), HEADACHE (Head was pounding) and CHILLS (Chills) had resolved. At the time of the report, HEADACHE (Throbbing forhead headaches) had not resolved and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow-up received contain Significant information- 2nd dose information, Contains updated adverse event information. Contains treatment medication information. On 05-Aug-2021: Follow up received contains Significant information-New event added-Fever,The start date of events- extreme fatigue, achy, nauseated changes from 23-MAR-2021 to 21-MAR-2021.Contains updated Event outcome-Recover, Contains new medical history, Reporter information-Address, Contains updated patient demographics- Patient, also include-Hight, Weight, Race and Ethnicity.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HERPES ZOSTER (shingles). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (shingles) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain
Clinical narrative: Soreness; Tiredness; Shivering; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 13-Apr-2021 and was forwarded to Moderna on 13-Apr-2021.    This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN (Soreness), FATIGUE (Tiredness) and CHILLS (Shivering) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Soreness), FATIGUE (Tiredness) and CHILLS (Shivering). At the time of the report, PAIN (Soreness), FATIGUE (Tiredness) and CHILLS (Shivering) outcome was unknown.         The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: gave Moderna Vaccine to a 17 & 1/2 year old male; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave Moderna Vaccine to a 17 & 1/2 year old male) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave Moderna Vaccine to a 17 & 1/2 year old male). On 13-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave Moderna Vaccine to a 17 & 1/2 year old male) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: quite a bit of soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (quite a bit of soreness) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN (quite a bit of soreness). At the time of the report, PAIN (quite a bit of soreness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient did not take any treatment for event.  No concomitant medications were reported.   This case was linked to MOD-2021-075099 (Patient Link).
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Hyperhidrosis, Pruritus, Rash
Clinical narrative: Chills; Light headed; Sweating; Itchy; Bumps all over body/bumps on neck/bumps on stomach/bumps on arms and legs/cluster of bumps; Hives; Rash; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed), HYPERHIDROSIS (Sweating), PRURITUS (Itchy), SWELLING (Bumps all over body/bumps on neck/bumps on stomach/bumps on arms and legs/cluster of bumps) and URTICARIA (Hives) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included IBUPROFEN for Menstrual disorder NOS, IRON for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021 at 9:40 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 10-Apr-2021, the patient experienced DIZZINESS (Light headed), HYPERHIDROSIS (Sweating), PRURITUS (Itchy), SWELLING (Bumps all over body/bumps on neck/bumps on stomach/bumps on arms and legs/cluster of bumps), URTICARIA (Hives) and RASH (Rash). On 10-Apr-2021 at 8:00 PM, the patient experienced CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at a dose of 1 dosage form. At the time of the report, DIZZINESS (Light headed), HYPERHIDROSIS (Sweating), PRURITUS (Itchy), SWELLING (Bumps all over body/bumps on neck/bumps on stomach/bumps on arms and legs/cluster of bumps), URTICARIA (Hives), RASH (Rash) and CHILLS (Chills) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Urticaria
Clinical narrative: Chills; Light headed; Sweating; Itchy; Bumps all over body/bumps on neck/bumps on stomach/bumps on arms and legs/cluster of bumps; Hives; Rash; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed), HYPERHIDROSIS (Sweating), PRURITUS (Itchy), SWELLING (Bumps all over body/bumps on neck/bumps on stomach/bumps on arms and legs/cluster of bumps) and URTICARIA (Hives) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included IBUPROFEN for Menstrual disorder NOS, IRON for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021 at 9:40 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 10-Apr-2021, the patient experienced DIZZINESS (Light headed), HYPERHIDROSIS (Sweating), PRURITUS (Itchy), SWELLING (Bumps all over body/bumps on neck/bumps on stomach/bumps on arms and legs/cluster of bumps), URTICARIA (Hives) and RASH (Rash). On 10-Apr-2021 at 8:00 PM, the patient experienced CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at a dose of 1 dosage form. At the time of the report, DIZZINESS (Light headed), HYPERHIDROSIS (Sweating), PRURITUS (Itchy), SWELLING (Bumps all over body/bumps on neck/bumps on stomach/bumps on arms and legs/cluster of bumps), URTICARIA (Hives), RASH (Rash) and CHILLS (Chills) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second dose is 42 days after my first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose is 42 days after my first dose) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose is 42 days after my first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose is 42 days after my first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site discolouration, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Injection site hot; injection site itchy; injfection site red; swollen area all the way up and down my arm; tender to touch; purple area; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen area all the way up and down my arm), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE DISCOLOURATION (purple area), VACCINATION SITE PRURITUS (injection site itchy) and VACCINATION SITE PAIN (tender to touch) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. :0161321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Complex regional pain syndrome. Concomitant products included DULOXETINE, CELECOXIB, METHOCARBAMOL and CLONAZEPAM for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (injection site itchy) and VACCINATION SITE ERYTHEMA (injfection site red). In April 2021, the patient experienced PERIPHERAL SWELLING (swollen area all the way up and down my arm), VACCINATION SITE DISCOLOURATION (purple area) and VACCINATION SITE PAIN (tender to touch). At the time of the report, PERIPHERAL SWELLING (swollen area all the way up and down my arm), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE DISCOLOURATION (purple area), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE PAIN (tender to touch) and VACCINATION SITE ERYTHEMA (injfection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Injection site hot; injection site itchy; injfection site red; swollen area all the way up and down my arm; tender to touch; purple area; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen area all the way up and down my arm), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE DISCOLOURATION (purple area), VACCINATION SITE PRURITUS (injection site itchy) and VACCINATION SITE PAIN (tender to touch) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. :0161321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Complex regional pain syndrome. Concomitant products included DULOXETINE, CELECOXIB, METHOCARBAMOL and CLONAZEPAM for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (injection site itchy) and VACCINATION SITE ERYTHEMA (injfection site red). In April 2021, the patient experienced PERIPHERAL SWELLING (swollen area all the way up and down my arm), VACCINATION SITE DISCOLOURATION (purple area) and VACCINATION SITE PAIN (tender to touch). At the time of the report, PERIPHERAL SWELLING (swollen area all the way up and down my arm), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE DISCOLOURATION (purple area), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE PAIN (tender to touch) and VACCINATION SITE ERYTHEMA (injfection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: the clinic was storing the vaccines improperly; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (the clinic was storing the vaccines improperly) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (the clinic was storing the vaccines improperly). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (the clinic was storing the vaccines improperly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   The number of patients is unknown in this case.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Pyrexia
Clinical narrative: Cough; headache; low grade fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), CHILLS (chills), HEADACHE (headache) and PYREXIA (low grade fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced CHILLS (chills) and PYREXIA (low grade fever). On 13-Apr-2021, the patient experienced COUGH (Cough) and HEADACHE (headache). At the time of the report, COUGH (Cough), CHILLS (chills), HEADACHE (headache) and PYREXIA (low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: felt bad for a few hours and was okay; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad for a few hours and was okay) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029421A) for COVID-19 vaccination.     Concurrent medical conditions included Depression, Anxiety disorder and Blood pressure high. Concomitant products included BUSPIRONE HYDROCHLORIDE (BUSPAR) for Anxiety, LORAZEPAM for Anxiety disorder, AMLODIPINE BESILATE (NORVASC) for Blood pressure high, BUPROPION HYDROCHLORIDE (WELLBUTRIN) and DESVENLAFAXINE SUCCINATE (PRISTIQ) for Depression, NIACIN for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced FEELING ABNORMAL (felt bad for a few hours and was okay). On 01-Mar-2021, FEELING ABNORMAL (felt bad for a few hours and was okay) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment was reported.   This case was linked to MOD-2021-074953 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Skin burning sensation, Urticaria
Clinical narrative: Itching, burning rash on arms, legs, stomach and back; Itching, burning rash on arms, legs, stomach and back; hives are getting worse and lasting longer each day; This spontaneous case was reported by a dentist and describes the occurrence of RASH PRURITIC (Itching, burning rash on arms, legs, stomach and back), SKIN BURNING SENSATION (Itching, burning rash on arms, legs, stomach and back) and URTICARIA (hives are getting worse and lasting longer each day) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 39K204) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism since 2008 and Allergic to cats. Concomitant products included THYROID (ARMOUR THYROID) for Hypothyroidism.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Itching, burning rash on arms, legs, stomach and back), SKIN BURNING SENSATION (Itching, burning rash on arms, legs, stomach and back) and URTICARIA (hives are getting worse and lasting longer each day). The patient was treated with CORTISONE for Itchy rash, at a dose of 1 dosage form. At the time of the report, RASH PRURITIC (Itching, burning rash on arms, legs, stomach and back), SKIN BURNING SENSATION (Itching, burning rash on arms, legs, stomach and back) and URTICARIA (hives are getting worse and lasting longer each day) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was prescribed antihistamines for events.   Events started 1 week after first vaccine and were worsened after second vaccine. The rash responds to cortisone tablets but comes back as soon as treatment stops.   This case was linked to MOD-2021-028881 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Patient demographic, medical history, concomitant medications , event verbatim updated. On 05-May-2021: No significant information was received. On 05-Jul-2021: Significant FU: Patients allergy history  and event updated
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Joints Pain; This spontaneous case was reported by a patient family member or friend and describes the occurrence of ARTHRALGIA (Joints Pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced ARTHRALGIA (Joints Pain). At the time of the report, ARTHRALGIA (Joints Pain) had not resolved.            No treatment was administered for event.   No concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Severe pain for months; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN (Severe pain for months) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Severe pain for months). At the time of the report, PAIN (Severe pain for months) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was on monoclonal antibodies for joint pain. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events were not applicable     This case was linked to MOD-2021-075055 (Patient Link).
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain in extremity
Clinical narrative: felt ill; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and MALAISE (felt ill) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included Fracture (fracture in back).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced MALAISE (felt ill). The patient was treated with Manual therapy (Ice pack) for Pain in extremity. At the time of the report, PAIN IN EXTREMITY (Sore arm) and MALAISE (felt ill) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing was delayed on an unknown date.       Concomitant products include muscle relaxers, and pain medication.  Treatment information was not provided.   This case was linked to MOD-2021-075141 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Diagnosed with Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with Covid-19) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced COVID-19 (Diagnosed with Covid-19). At the time of the report, COVID-19 (Diagnosed with Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Product dose omission issue, Rhinorrhoea
Clinical narrative: Beyond 42 days since 1st dose of vaccine, She has not received the second dose due to health reasons.; nasal/sinus drainage; cough; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (nasal/sinus drainage), COUGH (cough) and PRODUCT DOSE OMISSION ISSUE (Beyond 42 days since 1st dose of vaccine, She has not received the second dose due to health reasons.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic and Pollen allergy (severe sinus allergies due to the pollen).    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (nasal/sinus drainage), COUGH (cough) and PRODUCT DOSE OMISSION ISSUE (Beyond 42 days since 1st dose of vaccine, She has not received the second dose due to health reasons.). At the time of the report, RHINORRHOEA (nasal/sinus drainage), COUGH (cough) and PRODUCT DOSE OMISSION ISSUE (Beyond 42 days since 1st dose of vaccine, She has not received the second dose due to health reasons.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow up information received contains significant information- Event outcome updated for the events rhinorrhoea and Cough from unknown to recovered/resolved. Duration of reaction added for the evets rhinorrhoea and cough.